Search hospitals > Connecticut > New Haven

Yale Cancer Center

Claim this profile
New Haven, Connecticut 06510
Global Leader in Solid Tumors
Global Leader in Tumors
Conducts research for Cancer
Conducts research for Breast Cancer
Conducts research for Non-Small Cell Lung Cancer
408 reported clinical trials
39 medical researchers
Photo of Yale Cancer Center in New HavenPhoto of Yale Cancer Center in New HavenPhoto of Yale Cancer Center in New Haven

Summary

Yale Cancer Center is a medical facility located in New Haven, Connecticut. This center is recognized for care of Solid Tumors, Tumors, Cancer, Breast Cancer, Non-Small Cell Lung Cancer and other specialties. Yale Cancer Center is involved with conducting 408 clinical trials across 273 conditions. There are 39 research doctors associated with this hospital, such as Patricia M Lorusso, Alessandro Santin, Amer M. Zeidan, and Joseph W. Kim, MD.

Area of expertise

1Solid Tumors
Global Leader
Yale Cancer Center has run 77 trials for Solid Tumors. Some of their research focus areas include:
Stage IV
Stage III
KRAS positive
2Tumors
Global Leader
Yale Cancer Center has run 74 trials for Tumors. Some of their research focus areas include:
Stage IV
Stage III
MSI-H positive

Top PIs

Clinical Trials running at Yale Cancer Center

Breast Cancer
Cancer
Tumors
Solid Tumors
Non-Small Cell Lung Cancer
Prostate Cancer
Squamous Cell Carcinoma
Colorectal Cancer
Pancreatic Cancer
Endometrial Cancer
Image of trial facility.

Giredestrant + Everolimus

for Advanced or Metastatic Breast Cancer

This Phase III, randomized, open-label, multicenter study will evaluate the efficacy and safety of giredestrant plus everolimus compared with the physician's choice of endocrine therapy plus everolimus in participants with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative locally advanced or metastatic breast cancer who have had previous treatment with cyclin-dependent kinase 4/6 inhibitors (CDK4/6is) and endocrine therapy, either in the locally advanced/metastatic or the adjuvant setting.
Recruiting2 awards Phase 37 criteria
Image of trial facility.

Sacituzumab Govitecan

for Breast Cancer

The goal of this clinical study is to see if sacituzumab govitecan-hziy (SG) can improve life spans of people with HR+/HER2- metastatic breast cancer and their tumor does not grow or spread when compared to currently available standard treatments, such as paclitaxel, nab-paclitaxel or capecitabine. The primary objective is to compare the effect of SG relative to the treatment of physician's choice (TPC) on progression-free survival (PFS).
Recruiting2 awards Phase 3
Image of trial facility.

VLS-1488

for Advanced Cancer

This is a first-in-human phase I/II study to examine the safety, tolerability and preliminary efficacy of VLS-1488 in subjects with advanced cancers.
Recruiting1 award Phase 1 & 26 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Yale Cancer Center?
Yale Cancer Center is a medical facility located in New Haven, Connecticut. This center is recognized for care of Solid Tumors, Tumors, Cancer, Breast Cancer, Non-Small Cell Lung Cancer and other specialties. Yale Cancer Center is involved with conducting 408 clinical trials across 273 conditions. There are 39 research doctors associated with this hospital, such as Patricia M Lorusso, Alessandro Santin, Amer M. Zeidan, and Joseph W. Kim, MD.
Where is Yale Cancer Center located?
The Yale Cancer Center is located at 35 Park St, New Haven, CT 06519. For access, from I-95 or I-91, take the Route 34 connector and follow signs to the Air Rights Garage. From Wilbur Cross Parkway or Merritt Parkway, follow the respective directions to Route 34 or Ella T. Grasso Blvd, then to South Frontage Road, and enter the Air Rights Garage. Enter the building from the 4th floor of the parking garage and walk through the bridge to Smilow Cancer Hospital.
Who should I call to ask about financial aid or insurance network?
**Yale Cancer Center Hospital Financial Assistance and Insurance Departments** **Financial Assistance:** - **Phone:** 855-547-4584 - **Website:** [Financial Assistance Guidelines](https://www.ynhhs.org/patients-visitors/billing-insurance/FAP-guidelines) - **Programs:** - **Free Care:** For individuals with family income less than 2.5 times the federal poverty level. - **Discounted Care:** For uninsured patients with family income ≤ 5.5 times the Federal Poverty Level. - **Sliding Scale:** For insured patients with family income ≤ 5.5 times the Federal Poverty Level. **Insurance:** - **Phone:** 855-547-4584 - **Website:** [Insurance and Billing](https://www.ynhhs.org/patients-visitors/billing-insurance/) - **Services:** - Customer Service Staff available for billing and insurance inquiries. - Patient Registrar contacts patients before visits for insurance information. - Medication Assistance Program (MAP) for patients with high medication costs.
What insurance does Yale Cancer Center accept?
The Yale Cancer Center accepts a wide range of insurance plans, including but not limited to Aetna, Anthem BC/BS, Cigna, ConnectiCare, Medicaid, Medicare, TRICARE, UnitedHealthcare, and WellCare of Connecticut Medicare Advantage. It's crucial to verify with your insurance carrier that your chosen healthcare provider is in-network before scheduling an appointment. Failure to do so may result in out-of-pocket expenses for services rendered.
What awards or recognition has Yale Cancer Center received?
Yale Cancer Center and Smilow Cancer Hospital at Yale New Haven are renowned for their pioneering contributions to cancer research, including the development of chemotherapy treatments and therapeutic agents. They boast the first university-based Medical Oncology section in the U.S. and lead in cancer biology research. With six research programs led by national experts, and as Connecticut's only National Cancer Institute-designated comprehensive cancer center, they offer advanced clinical trials and comprehensive care.